Taro Pharmaceuticals (Israel)

Taro Pharmaceuticals (Israel)

Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer that was publicly listed in the New York Stock Exchange before it was acquired by Sun Pharma. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Taro Pharmaceuticals (Israel), Israel, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

63%


Total
Publications

52


Total Open
Publications

33


Total
Citations

2.4K


Open Access
Percentage

63%


Total
Publications

52


Total Open
Publications

33


Total
Citations

2.4K

Wikipedia

Website

download

Breakdown

46% 19% 0% 35%

Publisher Open

46%

Both

19%

Other Platform Open

0%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

34%OA Journal

OA Journal 34%

12

Hybrid 3%

1

No Guarantees 63%

22

Other Platform Open

Domain 100%

10

Other Internet 10%

1

Institution 0%

0

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
10
Europe PMC
Domain
1
DOI
Other Internet
1
1 / 1

Data updated 18 August 2025

Share

Share

Share